Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Coeptis Therapeutics Inc.

    NASDAQ: COEP · Real-Time Price · USD
    8.12
    -0.11 (-1.34%)
    At close: Jun 17, 2025, 3:18 PM

    Coeptis Therapeutics Statistics

    Share Statistics

    Coeptis Therapeutics has 3.51M shares outstanding. The number of shares has increased by -91.27% in one year.

    Shares Outstanding

    n/a
    		 3.51M

    Shares Change (YoY)

    n/a
    		 -91.27%

    Shares Change (QoQ)

    n/a
    		 3053.64%

    Owned by Institutions (%)

    n/a
    		 0.01%

    Shares Floating

    n/a
    		 3.02M

    Failed to Deliver (FTD) Shares

    n/a
    		 411

    FTD / Avg. Volume

    n/a
    		 0.72%

    Short Selling Information

    The latest short interest is 27.77K, so 0.79% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 27.77K

    Short % of Shares Out

    n/a
    		 0.79%

    Short % of Float

    n/a
    		 0.94%

    Short Ratio (days to cover)

    n/a
    		 1.04

    Valuation Ratios

    The PE ratio is -1.08 and the forward PE ratio is -2.39. Coeptis Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.08

    Forward PE

    n/a
    		 -2.39

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.32

    P/FCF Ratio

    n/a
    		 -1.59

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Coeptis Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.23, with a Debt / Equity ratio of 0.44.

    Current Ratio

    n/a
    		 0.23

    Quick Ratio

    n/a
    		 0.23

    Debt / Equity

    n/a
    		 0.44

    Debt / EBITDA

    n/a
    		 -0.14

    Debt / FCF

    n/a
    		 -0.21

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,962,800

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.06M

    Effective Tax Rate

    n/a
    		 9.78%

    Stock Price Statistics

    The stock price has increased by 32.44% in the last 52 weeks. The beta is -0.58, so Coeptis Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.58

    52-Week Price Change

    n/a
    		 32.44%

    50-Day Moving Average

    n/a
    		 9.37

    200-Day Moving Average

    n/a
    		 7.51

    Relative Strength Index (RSI)

    n/a
    		 39.63

    Average Volume (20 Days)

    n/a
    		 56,755

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -1.04M

    Operating Income

    n/a
    		 -10.05M

    Net Income

    n/a
    		 -9.81M

    EBITDA

    n/a
    		 -10.05M

    EBIT

    n/a
    		 -11.27M

    Earnings Per Share (EPS)

    n/a
    		 -5.1
    Full Income Statement

    Balance Sheet

    The company has 532.88K in cash and 1.4M in debt, giving a net cash position of -866.17K.

    Cash & Cash Equivalents

    n/a
    		 532.88K

    Total Debt

    n/a
    		 1.4M

    Net Cash

    n/a
    		 -866.17K

    Retained Earnings

    n/a
    		 -98.23M

    Total Assets

    n/a
    		 13.45M

    Working Capital

    n/a
    		 -1M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -6.65M and capital expenditures 0, giving a free cash flow of -6.65M.

    Operating Cash Flow

    n/a
    		 -6.65M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -6.65M

    FCF Per Share

    n/a
    		 -3.45
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    COEP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for COEP.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 31, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Dec 31, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 43.36

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist